注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Vaxart Inc是一家臨床階段的生物技術公司,主要開發基於其載體-佐劑-抗原標準化技術(VAAST)口服疫苗平台的口服重組疫苗。該公司的項目包括旨在預防冠狀病毒、諾如病毒、季節性流感和呼吸道合胞病毒(RSV)的片劑疫苗,以及人乳頭瘤病毒(HPV)的治療性疫苗。該公司的產品線包括諾如病毒疫苗,一種口服片劑疫苗,該疫苗正處於Ib期臨床試驗中;針對GI.1和 GII.4株諾如病毒株的二價口服片劑疫苗;流感疫苗,用於治療H1流感感染的II期臨床試驗;呼吸道合胞病毒疫苗;和冠狀病毒疫苗,該疫苗正處於治療SARS-CoV-2感染的II期臨床試驗中。該公司還在開發針對人乳頭瘤病毒引起的宮頸癌和不典型增生的治療性疫苗。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
David E. Wheadon | 65 | 2021 | Independent Lead Director |
James Robinson | 63 | - | Member of Manufacturing & Quality Advisory Board |
Steven Lo | 57 | 2024 | President, CEO & Director |
Stefan Gravenstein | - | 2021 | Member of Scientific & Clinical Advisory Board |
Gregory C. Gray | - | 2021 | Member of Scientific & Clinical Advisory Board |
John F. Carpenter | - | 2021 | Member of Manufacturing & Quality?Advisory?Board |
Robert B. Belshe | - | 2021 | Member of Scientific & Clinical Advisory Board |
Benjamin J. Del Tito | 68 | 2021 | Member of Manufacturing & Quality?Advisory?Board |
George R. Siber | 79 | 2021 | Member of Scientific & Clinical Advisory Board |
Harry B. Greenberg | - | 2021 | Member of Scientific & Clinical Advisory Board |
William Mark Watson | 74 | 2022 | Director |
Elaine J. Heron | 76 | 2022 | Director |
Ralph Baric | - | 2021 | Member of Scientific & Clinical Advisory Board |
Marion Pepper | - | 2021 | Member of Scientific & Clinical Advisory Board |
Vijay Jethwa | - | 2021 | Member of Manufacturing & Quality?Advisory?Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核